Ads
related to: crispr stock price today
Search results
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks via Yahoo Finance· 3 days agoRecently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 14 hours agoExpecting a jump from around $55 today to $95 in order to get $25 in annual profits six years from...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 2 days agoRegulatory, clinical, and competitive pressures all present uncertainty and potential challenges....
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
Zacks via Yahoo Finance· 7 days agoCRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims...
CRISPR Therapeutics’ (CRSP) Neutral Rating Reiterated at Cantor Fitzgerald
ETF DAILY NEWS· 3 days agoA number of other research analysts have also recently commented on CRSP. Needham & Company LLC reduced their price objective on CRISPR Therapeutics ...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 5 days agoTherapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the
We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
Simply Wall St. via Yahoo Finance· 6 days agoIts important for readers to be cognizant of the risks that can affect the company's operations, and...
Earnings call: Intellia Therapeutics reports robust Q1 progress By Investing.com
Investing.com· 6 days agoIntellia Therapeutics (NASDAQ: NASDAQ:NTLA) has made significant progress in the first quarter of...
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 4 days agoIt's in the process of launching its new gene editing therapy Casgevy, which it developed with ...
Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
Simply Wall St. via Yahoo Finance· 5 days agoCRISPR Therapeutics AG (NASDAQ:CRSP) shareholders will have a reason to smile today, with the...